Stocks · Health care · Pharmaceutical Preparations

NewAmsterdam Pharma Co N.V.

NAMS Clue Score25

Netherlands Fiscal year ends December CIK 0001936258 Results filed 5 Aug 2026

Add to watchlist

What the insiders did Net selling

Individual transactions

Insider

Date

Role

Action

Price

Amount

Michael H. Davidson

7 Jan 2026

Chief Executive Officer

Sold on a plan

11,582

—

no price

Mayur Ian Somaiya

5 Jan 2026

Chief Financial Officer

Sold on a plan

5,118

$33.25

$170.17K

Louise Frederika Kooij

5 Jan 2026

Chief Accounting Officer

Sold on a plan

2,647

$33.25

$88.01K

Johannes Jacob Pieter Kastelein

5 Jan 2026

Chief Scientific Officer

Sold on a plan

6,000

$33.25

$199.50K

Show all 45 transactions →

What was left out

Form 4 filings counted 28

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 4

Sales straight out of an exercise 33

Sales at will 6

Transactions with no price 1

Shares from compensation/vesting 2,037,465

History held since 3 Jan 2024